Showing 23,074 news articles about PEP

Filters Content type: Editors' picks Topic: PEP

Post-exposure prophylaxis involves taking a 28-day course of anti-HIV drugs, after possible exposure to HIV. It may be used by healthcare workers (occupational PEP) or after sex (post-exposure prophylaxis after sexual exposure, PEPSE, also known as non-occupational PEP or nPEP).

Hepatitis C treatment

Hepatitis C will be eradicated in Australia by 2026, researchers predict

Editor's pick
ABC Online
21 February 2017
Hepatitis C treatment

Egypt combats hepatitis C epidemic with state-run scheme

Editor's pick
Financial Times
23 January 2017
Hepatitis C treatment

Japan: Hepatitis C drug fakes found in Nara drugstore chain

Editor's pick
The Japan Times
18 January 2017
Pharmaceutical industry

The U.S. Government Should Buy Gilead For $156 Billion To Save Money On Hepatitis C

Editor's pick
Forbes
17 January 2017
Pharmaceutical industry

Merck wins $2.54 billion in hepatitis C drug trial against Gilead

Editor's pick
Reuters
16 December 2016
Hepatitis C symptoms & diagnosis

First WHO prequalified hepatitis C rapid test opens the door to expanded treatment

Editor's pick
World Health Organization
5 December 2016
Hepatitis C treatment

Hepatitis C drugs Australia's most expensive, cost taxpayers $1 billion in four months

Editor's pick
ABC Online
5 December 2016
Hepatitis C treatment

The Cost Of A Cure: Revisiting Medicare Part D And Hepatitis C Drugs

Editor's pick
Health Affairs (blog)
4 November 2016
Pharmaceutical industry

Gilead sales of Hepatitis C drugs slump

Editor's pick
MarketWatch
2 November 2016
Hepatitis C treatment

A promising Hep C program seems to be working — and it could be a model for other countries

Editor's pick
Business Insider
24 October 2016
Hepatitis C treatment

Punjab hepatitis control programme on verge of collapse

Editor's pick
Daily Times
18 October 2016
Hepatitis C treatment

Australia leading world in hepatitis C treatment; but disease more prevalent in Aboriginal people

Editor's pick
ABC Online
29 September 2016
Hepatitis C treatment

New Study: Negotiated Hepatitis C Prescription Drug Costs in United States Often Lower than in Price-Controlled European Countries and Japan

Editor's pick
Yahoo News
20 September 2016
Hepatitis B

ContraVir Reports New CRV431 Data Highlighting Synergistic Activity with CMX157 Against Hepatitis B

Editor's pick
ContraVir press release
12 September 2016
Hepatitis C treatment

Ethiopia unable to provide effective national response to viral hepatitis

Editor's pick
Healio
12 September 2016
Hepatitis B

Act now for a Hepatitis-free Indonesia

Editor's pick
Jakarta Post
7 September 2016
Access to healthcare

Doctors Without Borders urges Gilead to rethink its hepatitis C strategy in Ukraine

Editor's pick
STAT
7 September 2016
Hepatitis C treatment

VA estimates 107000 vets have undiagnosed or untreated hepatitis C

Editor's pick
Stars and Stripes
7 September 2016
Access to healthcare

High cost hampers treatment of hepatitis B, C in Vietnam: experts

Editor's pick
Thanh Nien Daily
31 August 2016
Pharmaceutical industry

University of Minnesota sues Gilead Sciences over hepatitis drugs

Editor's pick
Minneapolis Star Tribune
31 August 2016
Pharmaceutical industry

Hillary Clinton calls out drug maker Gilead over price of hepatitis C pills

Editor's pick
UPI.com
19 August 2016

Tata Trusts, Gilead sign MoU on viral hepatitis in India

Editor's pick
Business Standard
5 August 2016
Hepatitis C transmission & prevention

22.6m Nigerians suffering from Hepatitis

Editor's pick
Vanguard
2 August 2016
Access to healthcare

WHO Updates Patent Status Info For New Hepatitis C Medicines

Editor's pick
Intellectual Property Watch
21 July 2016